000 | 01317 a2200385 4500 | ||
---|---|---|---|
005 | 20250517192143.0 | ||
264 | 0 | _c20181024 | |
008 | 201810s 0 0 eng d | ||
022 | _a1878-1780 | ||
024 | 7 |
_a10.1016/j.diabet.2017.11.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeggio, M | |
245 | 0 | 0 |
_aLow-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk? _h[electronic resource] |
260 |
_bDiabetes & metabolism _cJun 2018 |
||
300 |
_a217-225 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAspirin _xadministration & dosage |
650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
650 | 0 | 4 |
_aDiabetes Complications _xprevention & control |
650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPrimary Prevention |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aBendini, M G | |
700 | 1 | _aCaldarone, E | |
700 | 1 | _aLombardi, M | |
700 | 1 | _aSeveri, P | |
700 | 1 | _aD'Emidio, S | |
700 | 1 | _aStavri, D C | |
700 | 1 | _aArmeni, M | |
700 | 1 | _aBravi, V | |
700 | 1 | _aMazza, A | |
773 | 0 |
_tDiabetes & metabolism _gvol. 44 _gno. 3 _gp. 217-225 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.diabet.2017.11.002 _zAvailable from publisher's website |
999 |
_c27905835 _d27905835 |